Concourse Financial Group Securities, Inc. Bio Rad Laboratories, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 497 shares of BIO stock, worth $129,811. This represents 0.01% of its overall portfolio holdings.

Number of Shares

497

Previous 539 7.79%

Holding current value

$129,811

Previous $180,000 9.44%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$313.15 - $374.28 $13,152 - $15,719	-42 Reduced 7.79%	497 $163,000
Q3 2024 Oct 10, 2024	BUY	$263.97 - $344.64 $527 - $689	2 Added 0.37%	539 $180,000
Q2 2024 Jul 23, 2024	BUY	$268.26 - $339.48 $22,533 - $28,516	84 Added 18.54%	537 $146,000
Q1 2024 Apr 30, 2024	BUY	$304.11 - $351.99 $13,989 - $16,191	46 Added 11.3%	453 $156,000
Q4 2023 Feb 07, 2024	SELL	$269.37 - $365.04 $2,424 - $3,285	-9 Reduced 2.16%	407 $131,000
Q3 2023 Oct 25, 2023	BUY	$350.25 - $422.63 $22,766 - $27,470	65 Added 18.52%	416 $149,000
Q2 2023 Aug 10, 2023	BUY	$359.49 - $486.4 $14,020 - $18,969	39 Added 12.5%	351 $133,000
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $5,442 - $6,539	-13 Reduced 4.0%	312 $149,000
Q4 2022 Jan 30, 2023	BUY	$351.71 - $456.01 $2,461 - $3,192	7 Added 2.2%	325 $0
Q3 2022 Nov 15, 2022	SELL	$412.59 - $563.26 $412 - $563	-1 Reduced 0.31%	318 $133,000
Q2 2022 Aug 09, 2022	BUY	$463.67 - $597.16 $463 - $597	1 Added 0.31%	319 $158,000
Q1 2022 May 09, 2022	SELL	$524.57 - $735.42 $10,491 - $14,708	-20 Reduced 5.92%	318 $179,000
Q4 2021 Feb 07, 2022	BUY	$708.84 - $794.68 $29,062 - $32,581	41 Added 13.8%	338 $255,000
Q3 2021 Nov 09, 2021	SELL	$657.71 - $825.77 $9,865 - $12,386	-15 Reduced 4.81%	297 $222,000
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $5,189 - $5,841	-9 Reduced 2.8%	312 $201,000
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $22,974 - $27,818	-42 Reduced 11.57%	321 $183,000
Q4 2020 Feb 02, 2021	SELL	$510.68 - $643.45 $9,702 - $12,225	-19 Reduced 4.97%	363 $212,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $21,358 - $25,173	47 Added 14.03%	382 $197,000
Q2 2020 Aug 13, 2020	SELL	$334.87 - $493.06 $1,674 - $2,465	-5 Reduced 1.47%	335 $151,000
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $108,803 - $139,083	340 New	340 $119,000
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$304.55 - $345.24 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	SELL	$286.93 - $312.59 $13,772 - $15,004	-48 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $26,691 - $37,771	-119 Reduced 71.26%	48 $14,000
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $4,622 - $6,489	-21 Reduced 11.17%	167 $38,000
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $54,384 - $61,316	188 New	188 $59,000

Others Institutions Holding BIO

# of Institutions

478

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Bio Rad Laboratories, Inc. Transaction History